OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Why does obesity cause diabetes?
Samuel Klein, Amalia Gastaldelli, Hannele Yki‐Järvinen, et al.
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 11-20
Open Access | Times Cited: 482

Showing 1-25 of 482 citing articles:

Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
Amalia Gastaldelli, Kenneth Cusi, Laura Fernández Landó, et al.
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 6, pp. 393-406
Closed Access | Times Cited: 317

Obesity, Inflammation, and Immune System in Osteoarthritis
Udhaya Nedunchezhiyan, Ibin Varughese, Antonia Rujia Sun, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 251

MAFLD: How is it different from NAFLD?
Cameron Gofton, Yadhavan Upendran, Ming‐Hua Zheng, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S17-S31
Open Access | Times Cited: 233

The Role of Obesity in Type 2 Diabetes Mellitus—An Overview
Preethi Chandrasekaran, Ralf Weiskirchen
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1882-1882
Open Access | Times Cited: 94

Gut microbiota induces DNA methylation via SCFAs predisposing obesity-prone individuals to diabetes
Wenqian Guo, Zengliang Zhang, Lingru Li, et al.
Pharmacological Research (2022) Vol. 182, pp. 106355-106355
Closed Access | Times Cited: 88

8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes–2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S145-S157
Open Access | Times Cited: 88

Relevance of body composition in phenotyping the obesities
Laura Salmón-Gómez, Victoria Catalán, Gema Frühbeck, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 5, pp. 809-823
Open Access | Times Cited: 70

Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes
Teresa Vilariño‐García, María Polonio-González, Antonio Pérez‐Pérez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2338-2338
Open Access | Times Cited: 60

Obesity in adults
Ildiko Lingvay, Ricardo V. Cohen, Carel W. le Roux, et al.
The Lancet (2024) Vol. 404, Iss. 10456, pp. 972-987
Closed Access | Times Cited: 59

GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications
Jonathan E. Campbell, Timo D. Müller, Brian Finan, et al.
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1519-1529
Open Access | Times Cited: 57

White adipocyte dysfunction and obesity-associated pathologies in humans
Carolina E. Hagberg, Kirsty L. Spalding
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 4, pp. 270-289
Closed Access | Times Cited: 55

β−Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives
Jürgen Wess, Antwi‐Boasiako Oteng, Osvaldo Rivera‐Gonzalez, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 854-884
Open Access | Times Cited: 54

Metabolic syndrome
Ian J. Neeland, Soo Lim, André Tchernof, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 45

Tirzepatide for Obesity Treatment and Diabetes Prevention
Ania M. Jastreboff, Carel W. le Roux, Adam Stefański, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 45

Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Maximilian Huttasch, Michael Roden, S. Kahl
Metabolism (2024) Vol. 157, pp. 155937-155937
Open Access | Times Cited: 33

Diabetes mellitus—Progress and opportunities in the evolving epidemic
E. Dale Abel, Anna L. Gloyn, Carmella Evans‐Molina, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3789-3820
Closed Access | Times Cited: 33

Hepatic glucose metabolism in the steatotic liver
Egeria Scoditti, Silvia Sabatini, Fabrizia Carli, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 5, pp. 319-334
Closed Access | Times Cited: 32

Animal models for type 1 and type 2 diabetes: advantages and limitations
Raj Kumar Singh, Mazaher Gholipourmalekabadi, Sasha H. Shafikhani
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 32

Visceral Adipose Tissue: The Hidden Culprit for Type 2 Diabetes
Sneha Dhokte, Krzysztof Czaja
Nutrients (2024) Vol. 16, Iss. 7, pp. 1015-1015
Open Access | Times Cited: 26

Metabolic Flexibility of the Heart: The Role of Fatty Acid Metabolism in Health, Heart Failure, and Cardiometabolic Diseases
Virginia Actis Dato, Stephan Lange, Yoshitake Cho
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1211-1211
Open Access | Times Cited: 18

Optimal obesity- and lipid-related indices for predicting type 2 diabetes in middle-aged and elderly Chinese
Xiaoyun Zhang, Ying Wang, Yuqing Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 18

8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes–2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S167-S180
Closed Access | Times Cited: 18

Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes
Haaglim Cho, Chien-Cheng Lai, Rémy Bonnavion, et al.
Science (2025) Vol. 387, Iss. 6734, pp. 674-682
Closed Access | Times Cited: 2

Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection
Yu‐Ping Chang, Ji‐Yuh Lee, Chi‐Yi Chen, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top